The articles on the work of BIOSANTECH SA.
Click on the images to read the articles or to start the slideshow.
Developed by the Marseilles researcher, curative vaccine against AIDS enters the test phase in humans, reports the newspaper La Provence, on Tuesday January 29th.
If the vaccine has been developed in the Institute of Structural Biology Timone , manufacturing was done in a pharmaceutical laboratory in Sophia Antipolis. After 13 years of research , 1500 first vaccines are now available to start these new tests. It is also a start-up of the technology , Biosantech , who financially supported this promising project .
Vaccine against AIDS: clinical trials in humans in France
The Marseille and his team are at the origin of a therapeutic vaccine against AIDS with the first clinical trials in humans will take place in Marseille in October. Already tested in macaques, the product was then very well, even with a case of the disease in remission for seven monkeys. As there will be as many humans? The scientist explains his ambitions Futura-Sciences.
16/07/2012 at 15:35 – By Janlou Chaput, Futura-Sciences
Curative vaccine against AIDS tested on humans
Wednesday, January 30, 2013
On 29 January, the Assistance Publique – Hôpitaux de Marseille (AP-HM) announces the start of clinical trials of a therapeutic vaccine against HIV. These tests will be supervised by Dr. Isabelle Ravaux, the infectious diseases of the Conception Hospital (AP-HM). It retails for Doctissimo hopes around this curative vaccine « Tat Oyi ».
AIDS. A Marseilles vaccine will be tested on humans
January 29, 2013
Manufactured by doctors of the hospital of Timone in Marseille, a curative vaccine against AIDS has been successful on animals. It will now be tested on 48 volunteers, according to La Provence quoted by France Info.
In 2001 was devised an « anti-AIDS molecule » that specifically targets the TAT protein, found responsible for the paralysis of the immune system in patients. After promising tests on rabbits and monkeys, research on this vaccine will stop for lack of funding.
More than ten years later, excavations were resumed through private funds. 48 HIV-positive patients have volunteered, so that the laboratory determines the most effective dose of the vaccine. The first tests will begin in a few days and the first results will be available early 2014.
This curative vaccine could replace the triple therapy.